Developer docs
API playgroundTry for free, no card

Search company profiles

Que Pharma

Full company profile

uuid002srfw

Namestring
Que Pharma
Legal namestring
Que Pharma Pvt. Ltd.
Websiteurl
quepharma.com
Company typeenum
Private
Founded yearint
1981
Descriptiontext

Que Pharma Pvt. Ltd. is an Indian pharmaceutical manufacturer founded in 1981 and headquartered in Surendranagar, Gujarat, operating a 38,000 sq ft WHO-GMP, ISO 9001:2008, and Schedule M certified production facility. The company develops and manufactures generic formulations across eleven therapeutic categories, with particular emphasis on antiallergic and antifungal products, and has built specialized capability in oral drug delivery formats including fast-release tablets and mouth-dissolving formulations such as Onda-Q MD. Its product portfolio is sold under proprietary brands, and the firm also offers contract manufacturing and third-party/loan-license (CMO/CDMO) production services to other pharmaceutical companies.

The company is led by three founders/promoters — Jaykant H. Sanghvi, Dilip D. Mair, and Rajendra H. Sanghvi — each with 35-43 years of industry experience. Que Pharma distributes its finished formulations in India through a field force and stockist network, and exports via local marketing partners to CIS countries, Asia, and Africa. The firm is privately held, has 11-50 employees, has not raised external funding, and has no public M&A history; its most recent strategic moves consist of two product launches (Racimol Tablets and Onda-Q MD) in November 2019, a website launch in April 2018, and ongoing maintenance of regulatory certifications for its single manufacturing site.

Short descriptiontext

Que Pharma is an Indian privately-held pharmaceutical manufacturer, founded 1981 in Gujarat, producing generic formulations across 11 therapeutic categories and offering contract manufacturing services for domestic and export markets in CIS, Asia, and Africa.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAhmedabad, India
HQ citystring
Ahmedabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, contract manufacturing services, generic pharmaceuticals, oral drug delivery, WHO-GMP certified facility
Industry2 codes
PRIMARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)
SECONDARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code2 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Contract Manufacturing
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmaceutical Product Manufacturing and Sales
TypeOne Time License
Description

Manufacturing and marketing of branded and generic pharmaceutical formulations including tablets, capsules, oral liquids, ointments. Revenue generated from sale of proprietary pharmaceutical products across various therapeutic categories.

2Contract Manufacturing Services
TypeProfessional Services
Description

Providing world-class contract manufacturing services to pharmaceutical companies worldwide. Services include purchasing of raw materials, production, packaging and quality control. Operating as a CMO/CDMO in India.

3Loan Licence Manufacturing
TypeProfessional Services
Description

Pharmaceutical contract manufacturing under loan license arrangements for third-party pharmaceutical companies.

quepharma.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Que Pharma develops, manufactures, and markets branded and generic pharmaceutical formulations across 11 therapeutic categories including antiallergic, antibiotics, antifungal, analgesic/antipyretic, anthelmintic, antacid, anti-malarial, dermatology, gastroenterology, NSAIDs, and vitamins/supplements. The company also provides end-to-end pharmaceutical contract manufacturing services (CMO/CDMO) for domestic and international pharmaceutical companies, covering raw material procurement, production, packaging, and quality control at its 38,000 sq. ft. WHO-GMP certified facility in Surendranagar, Gujarat.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • >75% dissolution rate within first 5 mins at all pH range for Racimol fast release Paracetamol
+1 more record
Product overview1 text field

Que Pharma is a GMP Certified pharmaceutical manufacturing company established in 1981, offering a comprehensive portfolio of branded and generic pharmaceutical formulations across 11 therapeutic categories: Antiallergic (CET-Q, CETQ-L, CETQ-LM, FEXEN products), Antibiotics (AZIQ, CEFA-Q, GERMICEF, LINQ, Q-CEF, Q-LIF, Q-MOX, QUIX, Q-VID products), Antifungal (LULIBAN, MYTRA, PHYTRA, Q-CAN, TINEAFIN, ULTRAKET products), Analgesic/Antipyretic & Anticold (DECOLD, HISTA products), Anthelmintic (Q-ANZOL products), Antacid/Alkliser (Q-CITRA), Anti Malarial (QUINTHER-LF), Dermatology (AD-Q-PLUS, DERMAC-GM, FILMOIST, NOURIHAIR, ROSACLIN products), Gastroenterology (MYFATE-O, OMI-Q, PENTAQ, RABIQ products), NSAID/Pain Management (ACQ, DF-PLUS, MEF, NIQ, RACIMOL products), and Vitamins/Supplements (BIOTIQ, FERRY-XT, FOLIB, FOXGARD, VITAFEROL products). The company also offers oral drug delivery innovation technologies including customized controlled-release drug delivery, bioavailability enhancement, taste masking, fast release tablets, melt-in-mouth tablets, and smaller sized solid orals. Contract manufacturing services are provided through flexible arrangements including raw material purchasing, production, packaging and quality control. QUE stands for Quality, Utility, and Efficiency/Economy.

Product and service12 records
1Contract Manufacturing Alliance
CategoryContract Manufacturing Service
2Loan Licence Manufacturing
CategoryContract Manufacturing Service
3Antiallergic Product Range (CET-Q, CETQ-L, CETQ-LM, FEXEN 120/180, FEXEN-M)
CategoryBranded Pharmaceutical Products
4Antibiotic Product Range (AZIQ, CEFA-Q, GERMICEF, LINQ, Q-CEF, Q-LIF, Q-MOX, QUIX, Q-VID)
CategoryBranded Pharmaceutical Products
5Antifungal Product Range (LULIBAN, MYTRA, PHYTRA, Q-CAN, TINEAFIN, ULTRAKET)
CategoryBranded Pharmaceutical Products
6Analgesic / Antipyretic & Anticold Product Range (DECOLD, HISTA)
CategoryBranded Pharmaceutical Products
7Anthelmintic Product Range (Q-ANZOL)
CategoryBranded Pharmaceutical Products
8Antacid/Alkliser Product Range (Q-CITRA)
CategoryBranded Pharmaceutical Products
9Anti-Malarial Product Range (QUINTHER-LF)
CategoryBranded Pharmaceutical Products
10Dermatology Product Range (AD-Q-PLUS, DERMAC-GM, FILMOIST, NOURIHAIR, Q-CAN KZ, Q-SCAB, RAYBEAT, ROSACLIN, SUPRABET, SUPRAMOM)
CategoryBranded Pharmaceutical Products
11Gastroenterology Product Range (MYFATE-O, OMI-Q, ONDAQ-MD, PENTAQ, PENTA-Q, RABIQ)
CategoryBranded Pharmaceutical Products
12NSAID / Pain Management Product Range (ACQ, DF-PLUS, MEF, NIQ, RACIMOL, VERIMEF)
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Companies in Asian Countries
Strategic tierMinorTypeOthers
Description

Tie-ups with companies having presence in Asian countries for distribution and marketing of pharmaceutical products. Strategic partnerships enable market reach in these regions through local expertise and distribution networks.

quepharma.com
2Companies in African Countries
Strategic tierMinorTypeOthers
Description

Partnerships with pharmaceutical companies in African countries for product distribution. Relationships established to serve the African pharmaceutical market with quality products.

quepharma.com
3Companies in CIS (Commonwealth of Independent States) Countries
Strategic tierCoreTypeOthers
Description

Extensive experience of working with clients in CIS countries. Que Pharma has the technical infrastructure and expertise required to develop healthcare and pharmaceutical products complying with the norms of CIS countries. Strategic partnerships for product supply and regulatory compliance.

quepharma.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Indian pharmaceutical company focused on branded generic formulations across anti-infective, gastrointestinal, ophthalmic, and nutrition categories with strong domestic field force. Comparable to Que Pharma in India-domestic branded generics focus and similar mid-market positioning.

TypeBroad incumbent
Description

Established Indian pharmaceutical company with branded and generic formulations, API manufacturing, and international presence. Larger than Que Pharma but operates in overlapping therapeutic categories and similar CMO-style partnerships for emerging markets.

3Recipharm
TypeBroad incumbent
Description

Global pharmaceutical CDMO providing contract development and manufacturing services across oral solids and other dosage forms. Comparable to Que Pharma's CMO/CDMO service line but operating globally at much larger scale.

4Wanbury
TypeDirect peer
Description

Indian pharma manufacturer with API and finished dosage form operations across similar therapeutic categories, serving domestic and emerging markets. Comparable to Que Pharma in manufacturing-focused generics model and emerging-market reach.

TypeDirect peer
Description

Indian generic pharmaceutical company with manufacturing for global markets including regulated and emerging geographies (US, Europe, Australia). Comparable to Que Pharma in generics-led portfolio with international distribution focus, though larger in scale.

TypeBroad incumbent
Description

One of India's largest generic pharmaceutical manufacturers with extensive API and formulation operations, significant contract manufacturing, and global reach. Overlaps with Que Pharma in generic formulations and CMO activities but at vastly greater scale.

TypeDirect peer
Description

Small-to-mid Indian specialty pharmaceutical manufacturer with branded generics and contract manufacturing operations across multiple therapeutic areas. Closely comparable to Que Pharma in scale, India-centric footprint, and combination of own-brand plus CMO business.

TypeBroad incumbent
Description

Vertically integrated Indian pharmaceutical manufacturer with strong presence in anti-malarial, anti-infective, and pain management categories — directly overlapping with Que Pharma's therapeutic mix. Larger scale and global API/formulation footprint.

9Indoco Remedies
TypeDirect peer
Description

Indian pharmaceutical manufacturer offering formulations across anti-infective, antiallergic, NSAID, and other therapeutic categories with both domestic branded generics and contract manufacturing. Highly comparable to Que Pharma in product mix, manufacturing model, and Indian mid-market positioning.

TypeDirect peer
Description

Indian CDMO offering contract development and manufacturing services across pharmaceuticals and specialty chemicals with GMP-certified facilities. Directly comparable to Que Pharma's CDMO/loan-license contract manufacturing business line.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Que Pharma

Pharmaceutical Contract Manufacturingquepharma.com

Que Pharma is an Indian privately-held pharmaceutical manufacturer, founded 1981 in Gujarat, producing generic formulations across 11 therapeutic categories and offering contract manufacturing services for domestic and export markets in CIS, Asia, and Africa.

What Que Pharma does

Que Pharma Pvt. Ltd. is an Indian pharmaceutical manufacturer founded in 1981 and headquartered in Surendranagar, Gujarat, operating a 38,000 sq ft WHO-GMP, ISO 9001:2008, and Schedule M certified production facility. The company develops and manufactures generic formulations across eleven therapeutic categories, with particular emphasis on antiallergic and antifungal products, and has built specialized capability in oral drug delivery formats including fast-release tablets and mouth-dissolving formulations such as Onda-Q MD. Its product portfolio is sold under proprietary brands, and the firm also offers contract manufacturing and third-party/loan-license (CMO/CDMO) production services to other pharmaceutical companies.

The company is led by three founders/promoters — Jaykant H. Sanghvi, Dilip D. Mair, and Rajendra H. Sanghvi — each with 35-43 years of industry experience. Que Pharma distributes its finished formulations in India through a field force and stockist network, and exports via local marketing partners to CIS countries, Asia, and Africa. The firm is privately held, has 11-50 employees, has not raised external funding, and has no public M&A history; its most recent strategic moves consist of two product launches (Racimol Tablets and Onda-Q MD) in November 2019, a website launch in April 2018, and ongoing maintenance of regulatory certifications for its single manufacturing site.

Que Pharma firmographics

Firmographics
Name
Que Pharma
Legal name
Que Pharma Pvt. Ltd.
Website
https://quepharma.com
Company type
Private
Founded year
1981
Operating status
Operating
Headcount range
11–50 employees
Short description
Que Pharma is an Indian privately-held pharmaceutical manufacturer, founded 1981 in Gujarat, producing generic formulations across 11 therapeutic categories and offering contract manufacturing services for domestic and export markets in CIS, Asia, and Africa.
Ownership category
akta.pro rank

Que Pharma industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)
SECONDARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Pharmaceutical manufacturing
  • Contract manufacturing services
  • Generic pharmaceuticals
  • Oral drug delivery
  • WHO-GMP certified facility

Where Que Pharma is headquartered

Location

Headquarters

HQ city
Ahmedabad
HQ country
India
HQ region
Asia

Offices2 records

Markets served

Que Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Pharmaceutical Product Manufacturing and Sales: Manufacturing and marketing of branded and generic pharmaceutical formulations including tablets, capsules, oral liquids, ointments. Revenue generated from sale of proprietary pharmaceutical products across various therapeutic categories.
  2. Contract Manufacturing Services: Providing world-class contract manufacturing services to pharmaceutical companies worldwide. Services include purchasing of raw materials, production, packaging and quality control. Operating as a CMO/CDMO in India.
  3. Loan Licence Manufacturing: Pharmaceutical contract manufacturing under loan license arrangements for third-party pharmaceutical companies.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Que Pharma product offering

Product offering

Core offering

Que Pharma develops, manufactures, and markets branded and generic pharmaceutical formulations across 11 therapeutic categories including antiallergic, antibiotics, antifungal, analgesic/antipyretic, anthelmintic, antacid, anti-malarial, dermatology, gastroenterology, NSAIDs, and vitamins/supplements. The company also provides end-to-end pharmaceutical contract manufacturing services (CMO/CDMO) for domestic and international pharmaceutical companies, covering raw material procurement, production, packaging, and quality control at its 38,000 sq. ft. WHO-GMP certified facility in Surendranagar, Gujarat.

Product overview

Que Pharma is a GMP Certified pharmaceutical manufacturing company established in 1981, offering a comprehensive portfolio of branded and generic pharmaceutical formulations across 11 therapeutic categories: Antiallergic (CET-Q, CETQ-L, CETQ-LM, FEXEN products), Antibiotics (AZIQ, CEFA-Q, GERMICEF, LINQ, Q-CEF, Q-LIF, Q-MOX, QUIX, Q-VID products), Antifungal (LULIBAN, MYTRA, PHYTRA, Q-CAN, TINEAFIN, ULTRAKET products), Analgesic/Antipyretic & Anticold (DECOLD, HISTA products), Anthelmintic (Q-ANZOL products), Antacid/Alkliser (Q-CITRA), Anti Malarial (QUINTHER-LF), Dermatology (AD-Q-PLUS, DERMAC-GM, FILMOIST, NOURIHAIR, ROSACLIN products), Gastroenterology (MYFATE-O, OMI-Q, PENTAQ, RABIQ products), NSAID/Pain Management (ACQ, DF-PLUS, MEF, NIQ, RACIMOL products), and Vitamins/Supplements (BIOTIQ, FERRY-XT, FOLIB, FOXGARD, VITAFEROL products). The company also offers oral drug delivery innovation technologies including customized controlled-release drug delivery, bioavailability enhancement, taste masking, fast release tablets, melt-in-mouth tablets, and smaller sized solid orals. Contract manufacturing services are provided through flexible arrangements including raw material purchasing, production, packaging and quality control. QUE stands for Quality, Utility, and Efficiency/Economy.

Differentiator

Problem solved

Functional benefit

Products and services

  • Contract Manufacturing Alliance
  • Loan Licence Manufacturing
  • Antiallergic Product Range (CET-Q, CETQ-L, CETQ-LM, FEXEN 120/180, FEXEN-M)
  • Antibiotic Product Range (AZIQ, CEFA-Q, GERMICEF, LINQ, Q-CEF, Q-LIF, Q-MOX, QUIX, Q-VID)
  • Antifungal Product Range (LULIBAN, MYTRA, PHYTRA, Q-CAN, TINEAFIN, ULTRAKET)
  • Analgesic / Antipyretic & Anticold Product Range (DECOLD, HISTA)
  • Anthelmintic Product Range (Q-ANZOL)
  • Antacid/Alkliser Product Range (Q-CITRA)
  • Anti-Malarial Product Range (QUINTHER-LF)
  • Dermatology Product Range (AD-Q-PLUS, DERMAC-GM, FILMOIST, NOURIHAIR, Q-CAN KZ, Q-SCAB, RAYBEAT, ROSACLIN, SUPRABET, SUPRAMOM)
  • Gastroenterology Product Range (MYFATE-O, OMI-Q, ONDAQ-MD, PENTAQ, PENTA-Q, RABIQ)
  • NSAID / Pain Management Product Range (ACQ, DF-PLUS, MEF, NIQ, RACIMOL, VERIMEF)

Quantifiable outcome

  • >75% dissolution rate within first 5 mins at all pH range for Racimol fast release Paracetamol
  • +1 more outcomes

Companies that use Que Pharma

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Que Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Que Pharma partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor and core.

  • Companies in Asian CountriesminorOthersTie-ups with companies having presence in Asian countries for distribution and marketing of pharmaceutical products. Strategic partnerships enable market reach in these regions through local expertise and distribution networks.
  • Companies in African CountriesminorOthersPartnerships with pharmaceutical companies in African countries for product distribution. Relationships established to serve the African pharmaceutical market with quality products.
  • Companies in CIS (Commonwealth of Independent States) CountriescoreOthersExtensive experience of working with clients in CIS countries. Que Pharma has the technical infrastructure and expertise required to develop healthcare and pharmaceutical products complying with the norms of CIS countries. Strategic partnerships for product supply and regulatory compliance.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Que Pharma competitors and assessment

Company assessment

Direct peers

  • FDC Limited: Indian pharmaceutical company focused on branded generic formulations across anti-infective, gastrointestinal, ophthalmic, and nutrition categories with strong domestic field force. Comparable to Que Pharma in India-domestic branded generics focus and similar mid-market positioning.
  • Wanbury: Indian pharma manufacturer with API and finished dosage form operations across similar therapeutic categories, serving domestic and emerging markets. Comparable to Que Pharma in manufacturing-focused generics model and emerging-market reach.
  • Marksans Pharma: Indian generic pharmaceutical company with manufacturing for global markets including regulated and emerging geographies (US, Europe, Australia). Comparable to Que Pharma in generics-led portfolio with international distribution focus, though larger in scale.
  • Vivimed Labs: Small-to-mid Indian specialty pharmaceutical manufacturer with branded generics and contract manufacturing operations across multiple therapeutic areas. Closely comparable to Que Pharma in scale, India-centric footprint, and combination of own-brand plus CMO business.
  • Indoco Remedies: Indian pharmaceutical manufacturer offering formulations across anti-infective, antiallergic, NSAID, and other therapeutic categories with both domestic branded generics and contract manufacturing. Highly comparable to Que Pharma in product mix, manufacturing model, and Indian mid-market positioning.
  • Hikal: Indian CDMO offering contract development and manufacturing services across pharmaceuticals and specialty chemicals with GMP-certified facilities. Directly comparable to Que Pharma's CDMO/loan-license contract manufacturing business line.

Broad incumbents

  • Unichem Laboratories: Established Indian pharmaceutical company with branded and generic formulations, API manufacturing, and international presence. Larger than Que Pharma but operates in overlapping therapeutic categories and similar CMO-style partnerships for emerging markets.
  • Recipharm: Global pharmaceutical CDMO providing contract development and manufacturing services across oral solids and other dosage forms. Comparable to Que Pharma's CMO/CDMO service line but operating globally at much larger scale.
  • Aurobindo Pharma: One of India's largest generic pharmaceutical manufacturers with extensive API and formulation operations, significant contract manufacturing, and global reach. Overlaps with Que Pharma in generic formulations and CMO activities but at vastly greater scale.
  • Ipca Laboratories: Vertically integrated Indian pharmaceutical manufacturer with strong presence in anti-malarial, anti-infective, and pain management categories — directly overlapping with Que Pharma's therapeutic mix. Larger scale and global API/formulation footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Que Pharma social profiles

Digital presence

Que Pharma compliance and trust

Trust signal

Compliance4 records

Que Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Que Pharma leadership team

Management profile

Number of profiles

Profiles3 records

Que Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Que Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Que Pharma

What does Que Pharma do?

Que Pharma develops, manufactures, and markets branded and generic pharmaceutical formulations across 11 therapeutic categories including antiallergic, antibiotics, antifungal, analgesic/antipyretic, anthelmintic, antacid, anti-malarial, dermatology, gastroenterology, NSAIDs, and vitamins/supplements. The company also provides end-to-end pharmaceutical contract manufacturing services (CMO/CDMO) for domestic and international pharmaceutical companies, covering raw material procurement, production, packaging, and quality control at its 38,000 sq. ft. WHO-GMP certified facility in Surendranagar, Gujarat.

Is Que Pharma a public or private company?

Que Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Que Pharma founded?

Que Pharma was founded in 1981. It employs 11 to 50 people.

Where is Que Pharma based?

Que Pharma is headquartered in Ahmedabad, India, in the Asia region.

How does Que Pharma make money?

Three revenue lines are on record. Pharmaceutical Product Manufacturing and Sales are the primary driver. The others are contract Manufacturing Services and loan Licence Manufacturing.

Who are Que Pharma's main competitors?

Direct peers on record are FDC Limited, Wanbury, Marksans Pharma, Vivimed Labs, Indoco Remedies and Hikal. Broad incumbents are Unichem Laboratories, Recipharm, Aurobindo Pharma and Ipca Laboratories.

Does Que Pharma have an API?

No public API is recorded for Que Pharma.

What industry is Que Pharma in?

Que Pharma's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO), with a secondary code of HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO. Its NAICS code is 3254 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales